The main intent of the UCLA CFAR Mucosal Immunology Core Laboratory (MICL) is to serve as an accessible and readily available resource for investigators seeking access to clinically-relevant human samples. The MICL offers a stream-lined process to foster multi-disciplinary interactions for further advances in HIV/AIDS, bridging basic, translational and clinical investigators in the area of HIV-related pathogenesis, treatment strategies and vaccine development. Especially for investigators without direct access to their own patient populations, the MICL provides Users with a coordinated, time-efficient and quality-enforced approach to acquire well-characterized human gastrointestinal (and other) mucosal tissue using our Core/MICL-specific. IRB-approved consent form to acquire samples, a unique MICL-based IRB-approved clinical trial registry for subject recruitment and an IRB-approved tissue bank for pilot studies starting with archived samples. To date, these projects have included acquiring human tissue/fluid/blood samples in pilot (and fully funded) studies of gene/stem cell therapy, nano-medicine approaches, mucosal immunization/tolerance, assessments of increased senescence in HIV-infected, impact of drugs of abuse, viral resistance and body compartmentalization as relates to virus, cells and target drugs. The MICL offers access to (i) a smoothly functioning small clinical trials unit with proven expertise in clinical management, subject recruitment and endoscopic procedures, (ii) a laboratory with a reputation of developing/optimizing novel mucosal assays and (iii) the ability to gain consultative input for protocols/grant applications so they are more firmly grounded in mucosal assessments and feasible, testable endpoints for pilot studies. The MICL assists Users with patient selection, tissue procurement, sample processing, and assistance in institutional review board submissions, refinements in hypothesis testing, detecting changes in the local versus systemic immune response and evaluating treatment responses at the tissue level.

Public Health Relevance

The MICL offers a critical, centralized, cost-effective and efficient resource for investigators seeking tissue/fluids from sexually-exposed mucosae for novel research efforts. These efforts are essential in better understanding HIV mucosal immunopathogenesis (prevention, therapeutics, eradication). With the recent paradigm shift with focus on tissue-impact of HIV, integrated efforts between bedside and bench can complement each other in far more constructive and interactive ways than has been evidenced in the past.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
5P30AI028697-25
Application #
8631028
Study Section
Special Emphasis Panel (ZAI1-UKS-A)
Project Start
Project End
Budget Start
2014-03-01
Budget End
2015-02-28
Support Year
25
Fiscal Year
2014
Total Cost
$181,453
Indirect Cost
$35,412
Name
University of California Los Angeles
Department
Type
DUNS #
092530369
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Beymer, Matthew R; Kofron, Ryan M; Tseng, Chi-Hong et al. (2018) Results from the post-exposure prophylaxis pilot program (P-QUAD) demonstration project in Los Angeles County. Int J STD AIDS 29:557-562
Swendeman, Dallas; Fehrenbacher, Anne E; Roy, Soma et al. (2018) Gender disparities in depression severity and coping among people living with HIV/AIDS in Kolkata, India. PLoS One 13:e0207055
Ramos, Juan C; Sparano, Joseph A; Rudek, Michelle A et al. (2018) Safety and Preliminary Efficacy of Vorinostat With R-EPOCH in High-risk HIV-associated Non-Hodgkin's Lymphoma (AMC-075). Clin Lymphoma Myeloma Leuk 18:180-190.e2
Matassoli, Flávio Lemos; Leão, Ihid Carneiro; Bezerra, Bruno Braz et al. (2018) Hydroxypropyl-Beta-Cyclodextrin Reduces Inflammatory Signaling from Monocytes: Possible Implications for Suppression of HIV Chronic Immune Activation. mSphere 3:
Woo, Jin Seok; Srikanth, Sonal; Kim, Kyun-Do et al. (2018) CRACR2A-Mediated TCR Signaling Promotes Local Effector Th1 and Th17 Responses. J Immunol 201:1174-1185
Jia, Qingmei; Bowen, Richard; Dillon, Barbara Jane et al. (2018) Single vector platform vaccine protects against lethal respiratory challenge with Tier 1 select agents of anthrax, plague, and tularemia. Sci Rep 8:7009
Arfer, Kodi B; Tomlinson, Mark; Mayekiso, Andile et al. (2018) Criterion validity of self-reports of alcohol, cannabis, and methamphetamine use among young men in Cape Town, South Africa. Int J Ment Health Addict 16:45-52
Van, Christina; Condro, Michael C; Lov, Kenny et al. (2018) PACAP/PAC1 Regulation of Inflammation via Catecholaminergic Neurons in a Model of Multiple Sclerosis. J Mol Neurosci :
Shannon, Chelsea Lee; Bristow, Claire; Hoff, Nicole et al. (2018) Acceptability and Feasibility of Rapid Chlamydial, Gonococcal, and Trichomonal Screening and Treatment in Pregnant Women in 6 Low- to Middle-Income Countries. Sex Transm Dis 45:673-676
Furler, Robert L; Nixon, Douglas F; Brantner, Christine A et al. (2018) TGF-? Sustains Tumor Progression through Biochemical and Mechanical Signal Transduction. Cancers (Basel) 10:

Showing the most recent 10 out of 942 publications